Drug Trial Radar · NCT00169299
Herbal Alternatives for Menopause Symptoms (HALT Study)
Last checked: Nov 20, 2026Latest source record: Sep 15, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
351
Actual
Start
Jun 2001
Primary completion
Not stated
Study completion Sep 2004
Sponsor
- Lead sponsor
- Kaiser PermanenteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Aging (NIA); National Center for Complementary and Integrative Health (NCCIH)
- First posted
- Sep 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- Female only, from 45 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Surveys indicate that 25 to 33% of women have moderate to severe menopausal symptoms including hot flashes, night sweats, and disturbed sleep. The treatment of choice in the medical community for these symptoms is hormone replacement therapy, which is estrogen and sometimes progestin. Many women also use over-the-counter herbal remedies. However, less is known about how well these products work, or their safety. Few have undergone the kind of rigorous testing required of prescription drugs and little is known about their long-term effectiveness in relieving symptoms. The purpose of this study is to compare several over-the-counter herbal remedies to hormone replacement therapy. Our primary aim is to look at the effects of these remedies on your self-reported menopausal symptoms. We will also be measuring their effects on other factors known to be affected by hormone replacement therapy: cholesterol, blood sugar, bone density, vaginal cell structure, and blood clotting.
Conditions
- Vasomotor Symptoms Associated With Menopause
Interventions
Black cohoshDrug
Multibotanical preparationDrug
Multibotanical preparation + dietary soy counselingDrug
Conjugated equine estrogen +/- medroxyprogesterone acetateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Self report daily diary of frequency and intensity of vasomotor symptoms at BL, 3, 6 and 12 months.
- Wiklund Menopause Symptom Checklist at BL, 3, 6 and 12 months.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Group Health Cooperative, Center for Health Studies
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.